Blueprint Medicines [BPMC] vs Vertex [VRTX] Detailed Comparison

Blueprint Medicines

NASDAQ

Vertex

NASDAQ

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Blueprint Medicines wins in 5 metrics, Vertex wins in 6 metrics, with 1 ties. Vertex appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Blueprint Medicines	Vertex	Better
P/E Ratio (TTM)	-119.59	32.82	Blueprint Medicines
Price-to-Book Ratio	24.15	7.09	Vertex
Debt-to-Equity Ratio	208.50	10.00	Vertex
PEG Ratio	-136.13	24.26	Blueprint Medicines
EV/EBITDA	-53.15	24.52	Blueprint Medicines
Profit Margin	-27.70%	-8.91%	Vertex
Operating Margin	-27.50%	37.22%	Vertex
EBITDA Margin	N/A	37.22%	N/A
Return on Equity	-47.71%	-5.64%	Vertex
Return on Assets	-9.75%	11.77%	Vertex
Free Cash Flow	$-197.22M	$-978.00M	Blueprint Medicines
Dividend Yield	0.00%	0.00%	Tie
1-Year Return	21.23%	-5.26%	Blueprint Medicines

Overview

Performance

Valuation

Financials

Short Interest

Dividends

Blueprint Medicines vs Vertex Price History Comparison

Loading Price Chart...

Key Statistics Comparison

Loading Statistics...

Metric	BPMC	VRTX
Market Information
Market Cap i
10 Day Avg. Volume i
90 Day Avg. Volume i
Last Close i
52 Week Range i
Valuation Metrics
P/E Ratio (TTM) i
Forward P/E i
PEG Ratio i
Price to Sales (TTM) i
Price to Book (MRQ) i
Financial Health
Profit Margin i
Operating Margin i
Return on Equity (TTM) i
Debt to Equity (MRQ) i
Dividends
Last 12-Month Dividend Yield i
Last 12-Month Dividend i
Payout Ratio i

Performance

Blueprint Medicines vs Vertex Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Income Statement (MRQ)

Balance Sheet & Liquidity Metrics (MRQ)

Cash Flow Statement Comparison (MRQ)

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...

Stock	1D	1W	1M	3M	6M	YTD

Stock	1Y	3Y	5Y	10Y	15Y	20Y

Metric	BPMC	VRTX
Shares Shorti	-	-
Short Ratioi	-	-
Short % of Floati	-	-
Average Daily Volume (10 Day)i	-	-
Average Daily Volume (90 Day)i	-	-
Shares Outstandingi	-	-
Float Sharesi	-	-
% Held by Insidersi	-	-
% Held by Institutionsi	-	-

Metric	BPMC	VRTX
Last 12-Month Dividend	-	-
Last 12-Month Dividend Yield	-	-
Projected Annual Dividend	-	-
Projected Dividend Yield	-	-
Payout Ratio	-	-
Ex-Dividend Date	-	-

Blueprint Medicines [BPMC] vs Vertex [VRTX] Detailed Comparison